VNRX-5133

CAS No. 1613268-23-7

VNRX-5133 ( VNRX5133 )

Catalog No. M12339 CAS No. 1613268-23-7

VNRX-5133 is a highly potent and specific beta-lactamase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1413 Get Quote
50MG 2862 Get Quote
100MG 3870 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    VNRX-5133
  • Note
    Research use only, not for human use.
  • Brief Description
    VNRX-5133 is a highly potent and specific beta-lactamase inhibitor.
  • Description
    VNRX-5133 is a highly potent and specific beta-lactamase inhibitor, for use in combination with a licensed beta-lactam antibioticBacterial Infection Phase 1 Clinical
  • Synonyms
    VNRX5133
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    Infection
  • Indication
    Bacterial Infection

Chemical Information

  • CAS Number
    1613268-23-7
  • Formula Weight
    389.26
  • Molecular Formula
    C19H28BN3O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    NCCN[C@@H]1CC[C@@H](CC(NC2B(O)OC(C(C(O)=O)=CC=C3)=C3C2)=O)CC1
  • Chemical Name
    3-(2-((1r,4r)-4-((2-aminoethyl)amino)cyclohexyl)acetamido)-2-hydroxy-3,4-dihydro-2H-benzo[e][1,2]oxaborinine-8-carboxylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Rufloxacin hydrochlo...

    Rufloxacin hydrochloride is a fluoroquinolone antibacterial and inhibits topoisomerase. Rufloxacin hydrochloride inhibits B-cell differentiation in human mononuclear cells.

  • G-418 disulfate

    An aminoglycoside antibiotic similar in structure to gentamicin B1; blocks polypeptide synthesis by inhibiting the elongation step in both prokaryotic and eukaryotic cells.

  • Icariside I

    Icariin is isolated from Epimedium herb. It can stimulate osteogenic differentiation of BMSCs and inhibit bone resorption activity of osteoclasts.